Compound Q&A
What is the market or research trend for Sapacitabine (CAS: 151823-14-2)?
Answer
Sapacitabine (CAS: 151823-14-2) is primarily used in oncology for the treatment of acute myeloid leukemia. Market trends indicate increasing research interest in its efficacy and safety, particularly in combination therapies. Studies are also exploring its potential in other hematological cancers. The trend suggests a steady market demand with ongoing clinical trials.
About
CAS No
151823-14-2
English Name
Sapacitabine
Molecular Formula
C26H42N4O5
Molecular Weight
490.6 g/mol
SMILES
CCCCCCCCCCCCCCCC(=O)NC1=NC(=O)N(C=C1)C2C(C(C(O2)CO)O)C#N
InChIKey
LBGFKUUHOPIEMA-PEARBKPGSA-N
Last Updated: 2025-12-30 05:21